Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease
Maseri, A.; Chierchia, S.; L'Abbate, A.
Circulation 62(6 Part 2): V3-V13
1980
ISSN/ISBN: 0009-7322 PMID: 7438380 Document Number: 163432
Document emailed within 1 workday
Related Documents
Bodnenkova, G.M.; Lizarev, A.V. 2005: Pathogenetic role of immune reactivity disorders in mechanisms underlying relations between hypothalamus-hypophysis-adrenals and thyroid systems in vibration disease Meditsina Truda i Promyshlennaia Ekologiia 12: 25-27Caraceni, P.; Gasbarrini, A.; Ryu, H.S.; Fagiuoli, S.; Degli Esposti, S.; Borle, A.B.; Van Thiel, D.H. 1994: Pathogenetic mechanisms underlying reoxygenation injury of perfused rat hepatocytes Transplantation Proceedings 26(6): 3393-3394
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Pincelli, C.; Schafer, P.H.; French, L.E.; Augustin, M.; Krueger, J.G. 2018: Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis Journal of Drugs in Dermatology: Jdd 17(8): 835-840
Arutiunian, V.M.; Grigorian, E.G.; Karagezian, K.G.; Vasilian, A.A.; Arutiunian, M.S.; Ovsian, G.A. 1999: Possible explanations of molecular mechanisms underlying etiology and pathogenesis of periodic disease Klinicheskaia Meditsina 77(11): 57-59
Gerlach, M.; Desser, H.; Youdim, M.B.; Riederer, P. 1996: New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline Journal of Neural Transmission. Supplementum 48: 7-21
Sluiter, W.; Pietersma, A.; Lamers, J.M.; Koster, J.F. 1993: Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression Journal of Cardiovascular Pharmacology 22(Suppl): S37-S44
Kovaleva, I.I.; Lebedeva, A.V.; Shomakhova, M.M.; Magomedov, R.A. 2011: Migraine and epilepsy: clinical features and common pathogenetic mechanisms Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(10 Part 2): 59-62
Puddu, G.M.; Zito, M.; D'Andrea, L.; Cervone, C.; Lamanna, P.; Abate, G. 1996: Clinical aspects and pathogenetic mechanisms of cognitive impairment in arterial hypertension Minerva Cardioangiologica 44(6): 285-297
Agasarov, L.G. 1991: Pathogenetic mechanisms of sex disorders in the clinical picture of vertebrogenic pain syndromes Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(5): 70-73
Kozhevnikova, S.A.; Budnevskiy, A.V.; Ovsyannikov, E.S.; Malysh, E.Y.; Belov, V.N. 2016: Chronic obstructive pulmonary disease and diabetes: a look at the epidemiology, pathogenetic mechanisms, treatment Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 60(4): 122-127
Angelini, C. 2004: Limb-girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms Acta Myologica: Myopathies and Cardiomyopathies: Official Journal of the Mediterranean Society of Myology 23(3): 130-136
Roa, B.B.; Garcia, C.A.; Lupski, J.R. 1991: Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy International Journal of Neurology 25-26: 97-107
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Schmidt, G.; Barthel, P.; Goedel-Meinen, L.; Baedeker, W.; Ulm, K. 1988: Spontaneous variability of ventricular arrhythmias in relation to the kind and extent of underlying heart disease Zeitschrift für Kardiologie 77(8): 523-526
Jiang, H.; Ma, L.-J.; Cong, H.-L.; Jiang, N.; Mao, Y.-M.; Xu, M.-L.; Cui, R.-Z. 2009: Expression of angiotensin Ii receptor subtypes in atrial fibrillation underlying rheumatic heart disease Zhonghua Nei Ke Za Zhi 48(7): 535-538
Manelis, G.; Shasha, S.; Churi, O.; Manelis, J.; Cohen, A. 1974: Prevalence of atherosclerotic heart disease among the Druze of Western Galilee Harefuah 86(10): 493-496
Gifford, R.W. 1983: Antihypertensive therapy and survival of patients with atherosclerotic heart disease Mayo Clinic Proceedings 58(4): 275-276
Lau, J.Y. 1998: Mechanisms of hepatic toxicity. IV. Pathogenetic mechanisms involved in hepatitis C virus-inducedliver diseases American Journal of Physiology 275(6): G1217-G1220
Sommerschild, H.T. 2001: Is infection a pathogenetic factor in coronary heart disease? Ugeskrift for Laeger 163(13): 1834-1842